Chiffres calculés à partir des déclarations réglementaires officielles — .
Analystesobjectif 87.5 USD (+2%) · consensus 4.18/5 · 16 achat · 6 conserver · 0 vente
Détentioninitiés 0.37% · institutions 94.3% · vente à découvert 4.9% du flottant · 4.91j pour couvrir
En USD · au Nov 2, 2026
Interroger la machine
Recherchez et comparez les opérations d’initiés, les sociétés et leurs statistiques en langage courant. Votre question devient une requête sur les données disponibles, pas une conversation ni un conseil en investissement.
Données de GE HealthCare Technologies Inc. uniquement. Pas de recherche web. Les statistiques globales d’un initié sont exclues.
Une recherche exécutée consomme un crédit, même sans résultat. Les erreurs et les questions non prises en charge ne consomment rien.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Source des informations de marché · Nov 2, 2026
Périodes présentes dans les registres consultés. Elles ne certifient pas les dates juridiques de changement de nom.
Identité selon la SEC · Nov 2, 2026
Chronologie sur le marché · historique complet
10 achats13 ventes— cours de clôturebarre = volume usd, échelle √cliquez sur une période pour filtrer le tableau
| Initié | Type | Valeur · USD | Signaux | Détail | |
|---|---|---|---|---|---|
| Grogan William K | AttributionD (dérivé) | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC | ||
| Grogan William K | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC | ||
| Grogan William K | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC | ||
| Estrampes Catherine | Autre | $35.8K | SEC | ||
| Rackliffe Philip | Autre | $56.3K | SEC | ||
| Arduini Peter J | Autre | $444.7K | SEC | ||
| Newcomb George A. | Autre | $7.9K | SEC | ||
| Jimenez Frank Rhistorique | Autre | $104.4K | SEC | ||
| Holton Adam Y | Autre | $47.5K | SEC | ||
| O'Neill Kevin Michael | Autre | $50.7K | SEC | ||
| Kass-Hout Taha | Autre | $106K | SEC | ||
| Bankes Jeannette | Autre | $75.8K | SEC | ||
| Arduini Peter J | Autre | $430.4K | SEC | ||
| Rackliffe Philip | Autre | $20.7K | SEC | ||
| Jimenez Frank Rhistorique | Autre | $124.7K | SEC | ||
| Jimenez Frank Rhistorique | Autre | $98.3K | SEC | ||
| Kass-Hout Taha | Autre | $117.1K | SEC | ||
| Kass-Hout Taha | Autre | $92.3K | SEC | ||
| Rackliffe Philip | Autre | $16.1K | SEC | ||
| Arduini Peter J | Autre | $389.8K | SEC | ||
| Holton Adam Y | Autre | $46.9K | SEC | ||
| Rackliffe Philip | Autre | $24.2K | SEC | ||
| Holton Adam Y | Autre | $100.2K | Taille inhabituelle | SEC | |
| Lobo Kevin | Achat | $641.8K | conv 79GroupéPremier en 12 mois | SEC | |
| Rackliffe Philip | Attribution | n.d. (Transaction sans contrepartie en espèces : la déclaration indique un prix nul (attribution, don, exercice)) | SEC |